HedgePath Pharmaceuticals Inc.

(HPPI)

By |

Profile

HedgePath Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes therapeutics for the patients with cancer. The firm's main focus is on the development of therapies for skin, lung and prostate cancers in the United States of America market. Its product portfolio consists of Itraconazole and Suba technology.

Contact Information

Website: www.hedgepathpharma.com
Email: info@cbi-biotech.com
Main Phone: +1 813 864-2559
Address: 324 S. Hyde Park Avenue
Address 2: Suite 350
State: FL
City / Town: Tampa
Country: USA
Postal Code: 33606

Issuer Information

Exchange: OTCQB
CEO: William X. Guo
Employees: 3
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.16 $ 0.0596 (59.54%)
Last Price 0.16 Change $ 0.0596 Change % 59.54 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.16 High 0.16 Low 0.16 Prev Close 0.10
Last Trade Volume 325 52 Wk Hi 0.38 52 Wk Low 0.0888
Market Cap 59.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 369,959,064.00 EPS (TTM) -0.01 PE Ratio N/A Exchange OTCQB
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Paul D'Sylva 1,000
Paul D'Sylva 1,000
Paul D'Sylva 1,000
Paul D'Sylva 1,000
Paul D'Sylva 1,000
Paul D'Sylva 1,000
Paul D'Sylva 1,000
Last 10 Sell Shares
Paul D'Sylva 1,000